Medical Technology

News

• • Ad hoc 2026

  Cicor and Singapore based EDMI agree to enter into a strategic outsourcing agreement

  Ad hoc announcement pursuant to Art. 53 LR

  07/28/2026

  Bronschhofen, 28 July, 2026 – Cicor Group (SIX Swiss Exchange: CICN) today announced a strategic manufacturing partnership with EDMI Limited (EDMI), a Singapore-headquartered global leader in intelligent energy solutions. The Board of Directors of both companies have agreed that Cicor will acquire their subsidiary of the Johor (Malaysia) manufacturing site EDMI Electronics Sdn. Bhd. and that the companies enter into a long term strategic manufacturing partnership with annual revenue for Cicor expected to exceed USD 50 million. The completion of the transaction is subject to customary closing conditions and approval by the relevant authorities in Malaysia, which is expected during the fourth quarter of 2026.

  Read more

  Read more
• • Ad hoc 2026

  Cicor reports strong H1 order intake with a book-to-bill ratio of 1.2 and returns to organic growth in Q2

  Ad hoc announcement pursuant to Art. 53 LR

  07/22/2026

  Bronschhofen, 22 July 2026 – Cicor Group (SIX Swiss Exchange: CICN) achieved strong growth in revenue and orders in the first half, while profitability and cash conversion reflected the ongoing integration phase and supply chain challenges. Revenue increased by 19% to CHF 334.1 million (H1 2025: CHF 280.7 million). Order intake rose by 39.8% to CHF 399.8 million (H1 2025: CHF 286.0 million). This resulted in a book-to-bill ratio of 1.2, marking the fifth consecutive quarter above one and providing strong visibility for future growth. Organic growth of 0% in the first half was affected by supply chain constraints and component availability but became positive in the second quarter with +5.3%. Adjusted[1] EBITDA amounted to CHF 28 million, corresponding to an adjusted margin of 8.4%. The integration of the businesses acquired in 2025 is progressing according to plan, while production transfers, capacity expansion and integration activities temporarily weighed on operating profitability in the first half. The integration and profitability programme, initiated in the first half of 2026, has been largely completed. It is expected to deliver recurring annual EBITDA improvements of more than CHF 10 million, with the full run-rate expected to be achieved during the third quarter.

  Read more

  Read more
• • Ad hoc 2026

  Cicor announces divestiture of Tunisia and implements an integration and productivity programme with above CHF 10 million EBITDA improvements

  Ad hoc announcement pursuant to Art. 53 LR

  06/16/2026

  Bronschhofen, 16 June 2026 – Cicor Group (SIX Swiss Exchange: CICN) expects recurring annual EBITDA improvements of more than CHF 10 million from a profitability improvement programme supporting the integration of its 2025 acquisitions. The programme includes the divestiture of the Tunisian facility, production ramp-up and transfers at several sites and operational optimisation measures across the Group. One-time implementation costs in the mid-single-digit CHF million range are expected in 2026, primarily in the first half of the year whereas a substantial portion of financial benefits is already expected for the second half of this year. Cicor therefore confirms its financial guidance for 2026.

  Read more

  Read more
• Load more